Score-based prediction model for female hepatocellular carcinoma surveillance in asymptotic HBsAg carriers: a...

Existing hepatocellular carcinoma (HCC) prediction models lack transferability and generalizability when applied to female populations, resulting in diminished performance and inadequate tools for accurate HCC risk stratification among females. This study aims to develop and validate a score-based prediction model for early detection of HCC in female hepatitis B surface antigen (HBsAg) carriers.

Participants were recruited from a multicenter prospective cohort engaged in liver cancer screening across China including seven high-risk rural areas and one additional high-risk rural area. The study involved 7080 females as the derivation cohort and 2069 as the validation cohort, with all participants aged 35-70 years and HBsAg positive. Laboratory tests and epidemiological surveys were conducted. Key predictor variables were identified through LASSO regression analysis, and score-based prediction models were developed based on Cox proportional hazards model. Model performance including discrimination and calibration was evaluated, and compared to existing prediction models and screening strategies.

After a median follow-up of 3.69 and 5.42 years, 147 and 45 HCC cases were identified in the derivation and validation cohorts, respectively. The female HCC (HCCF) model incorporating five independent variables: age, α-fetoprotein (AFP), albumin, alanine aminotransferase, and platelet, showed excellent performance with an area under the receiver operating characteristic curve (AUC) of 0.82 (95 % CI: 0.78-0.86). The HCCF-Enhanced model which included cirrhosis, achieved an AUC of 0.85 (95 % CI: 0.81-0.89). Both models demonstrated superior predictive performance than existing models, with strong predictive accuracy in the validation cohort: AUCs of 0.83 (95 % CI: 0.77-0.89) and 0.88 (95 % CI: 0.83-0.92), respectively. The HCCF model, at a score threshold of 7, achieved the largest Youden's index and identified 32.80 % of high-risk individuals. When combined with ultrasonography (US), the model detected 37 additional cases, significantly improved screening sensitivity and accuracy compared to the traditional AFP plus US strategy.

The developed HCCF models with good performance for HCC prediction in HBsAg-positive females significantly improve screening efficiency and provide an effective tool for surveillance, ultimately helping to optimize prevention and management strategies for HCC.